{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123682","form_type":"8-K","ticker":"CGC","cik":"0001737927","company_name":"Canopy Growth Corp","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.410745+00:00","generated_at":"2026-05-30T02:54:24.462926+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M","bullets":["Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.","Adjusted EBITDA loss $5.5M, improved 54% YoY; net loss from cont. ops $131.6M.","Canada medical revenue +16% YoY; Storz & Bickel +32% on Germany reform and US sales.","Early prepayment reduced secured term loan by US$100M; cash balance $231M.","Canopy USA closed Wana acquisition post-quarter; Acreage acquisition on track for H1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123682","json":"https://secwatch.observer/filing/0000950170-24-123682.json","markdown":"https://secwatch.observer/filing/0000950170-24-123682.md","text":"https://secwatch.observer/filing/0000950170-24-123682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/0000950170-24-123682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/cgc-20241108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:54:24.462926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}